| 1. | MAGLAKELIDZE, M., ARENSIA Exploratory Medicine LLC, Georgia, YAU, T., Universitatea Chineză din Hong Kong, China, BULAT, I., dr.hab, YEN, C., National Cheng Kung University Hospital Taiwan, China, CHAO, Y., Taipei Veterens General Hospital, Taipei City, China, BAI, L., China Medical University Hospital, Taichung, China, GOOD, A., China Medical University Hospital, Taichung, China, EDE, N., China Medical University Hospital, Taichung, China, CHONG, L., China Medical University Hospital, Taichung, China, TANASANVIMON, S., King Chulalongkorn Memorial Hospital, Bangkok, China A phase 1b study of IMU-131 her2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction. Annals of oncology. 2019, nr. 10(30), 0-0. ISSN 0923-7534 ISSNe 1569-8041. |
